Numerous studies have shown a connection between increased OPN secretion and many other cancers, including glioblastoma, breast and prostate cancer, squamous cell carcinoma, melanoma, and OS. In lung cancer, overexpression of OPN is linked to both patient survival and the results of therapeutic interventions like surgery, chemotherapy, or radiotherapy. The gene discussed is SPP1; the disease is prostate carcinoma.